Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|7|2|100-104

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.7, Iss.2, 2012-01, pp. : 100-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension

By Chhina Mantej K   Nargues Weir   Grant Geraldine M   Nathan Steven D  

Future Cardiology, Vol. 6, Iss. 1, 2010-01 ,pp. : 19-35

Future Medicine

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension in Systemic Sclerosis: Clinical Manifestations, Pathophysiology, Evaluation, and Management

By Ramirez Allan  

Treatments in Respiratory Medicine, Vol. 3, Iss. 6, 2004-01 ,pp. : 339-352

Adis International

Access to resources Recommend Favorite

Current Treatment of the Pulmonary Arterial Hypertension

By  

Current Respiratory Medicine Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacotherapy and Drug Development for Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension: A Comprehensive Review of Pharmacological Treatment

By Erika Berman Rosenzweig   Barst Robyn J.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 2, 2006-01 ,pp. : 117-127

Adis International

Access to resources Recommend Favorite